Effects of seaweed on blood glucose
Recruiting
- Conditions
- diabetes type 2
- Registration Number
- NL-OMON20760
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Patients with T2DM and BMI>25
- All adults; age = 18 years
- Diabetes based on criteria of ADA
Exclusion Criteria
- Type 1 or monogenetic forms of diabetes.
- Thyroid disease
- Pregnancy
- Usage of corticosteroids
- Usage of blood anti-coagulants
- History of heart failure or recent myocardial infarction within 3 months
- Transplantation
- Allergy for shellfish
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference between the mean blood glucose levels measured during the first week of usual diet and during week 2 to 6 when daily seaweed is consumed.
- Secondary Outcome Measures
Name Time Method differences between week 1 and week 6 in terms of body weight (kg); HbA1c and total daily insulin use, and fasting blood glucose levels (Mmol/L) in addition to the continuously monitored glucose levels. Levels of total cholesterol, LDL-cholesterol, HDL-cholesterol, lipoprotein (a) (g/L), apoB100/48 (Mmol/L) and triglycerides (Mmol/L) (measured using routine laboratory analysis) will be analyzed, and pulse wave velocity and blood pressure (mmHg) and cytokines.